R3.5 BILLION IN DEDICATED UNDERWRITING CAPACITY
Failure in pharmaceutical manufacturing does not stay contained. It moves, across production, validation, compliance, and supply.
Alpha operates inside regulated pharmaceutical production where every process is validated, systems are interdependent, and disruption must be contained immediately to protect product integrity and regulatory standing. From advanced laboratories and manufacturing facilities to cleanrooms and controlled storage, protection extends across the full production system.
The risk is not the initial event. It is what follows. Batch loss, validation breakdown, delayed release, and compounding operational downtime. These are not isolated incidents, they are connected consequences.
Alpha is built around this understanding.
We insure specialised production equipment, validated systems, critical utilities, and regulated stock, structuring protection for operations where interruption escalates rapidly and recovery time determines the outcome.
Our underwriting is grounded in how GMP compliant operations function in practice. Processes are validated, dependencies are tight, and recovery must be controlled with precision.
Protection is structured around where failure actually manifests:
The objective is clear. Contain the impact. Restore the operation.
In pharmaceutical manufacturing, recovery time is as critical as the event itself.
WHY ALPHA
Alpha is not aligned to pharmaceutical risk. It is engineered to perform within it.
For pharmaceutical operations where recovery time defines the outcome.
Protecting Futures | Mitigating Risk
www.alpha.co.za
